We are live on
!
Find out more
Stifel Financial Portfolio holdings
AUM
$109B
1-Year Est. Return
21.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.33%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+351.88%
AUM
$66.6B
AUM Growth
+$5.55B
(+9.1%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
3,449
New
177
Increased
1,464
Reduced
1,530
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$362M |
| 2 |
Tractor Supply
TSCO
|
+$274M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.7M |
| 4 |
Biohaven
BHVN
|
+$79.4M |
| 5 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$464M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$363M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$59.5M |
| 4 |
Duke Energy
DUK
|
+$58.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.39% |
| 2 | Healthcare | 12.41% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Staples | 9.52% |
| 5 | Financials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
First Trust Emerging Markets AlphaDEX Fund
FEM
$774M
| $1.27M | ﹤0.01% |
60,163
-745
| -1% | -$14.9K |
|
1827
Nicolet Bankshares
NIC
$3.67B
| $1.26M | ﹤0.01% |
15,822
+20
| +0.1% | +$1.56K |
|
1828
Clean Energy Fuels
CLNE
$407M
| $1.26M | ﹤0.01% |
242,633
-2,343
| -1% | -$14.4K |
|
1829
PIMCO Dynamic Income Fund
PDI
$7.41B
| $1.26M | ﹤0.01% |
68,270
-18,613
| -21% | -$365K |
|
1830
PureCycle Technologies
PCT
$1.41B
| $1.26M | ﹤0.01% |
186,393
+44,056
| +31% | +$318K |
|
|
ROIC
1831
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.26M | ﹤0.01% |
83,782
-249
| -0.3% | -$3.65K |
|
1832
Cohu
COHU
$2.49B
| $1.26M | ﹤0.01% |
39,289
-12,750
| -25% | -$413K |
|
1833
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $1.26M | ﹤0.01% |
26,298
+1,148
| +5% | +$54.7K |
|
1834
Petrobras
PBR
$120B
| $1.26M | ﹤0.01% |
118,025
-55,613
| -32% | -$672K |
|
1835
Avient
AVNT
$3.95B
| $1.25M | ﹤0.01% |
36,973
+432
| +1% | +$14.2K |
|
1836
nCino
NCNO
$2.07B
| $1.25M | ﹤0.01% |
47,172
-9,410
| -17% | -$265K |
|
1837
Axalta
AXTA
$8.18B
| $1.24M | ﹤0.01% |
48,779
-6,419
| -12% | -$159K |
|
1838
J&J Snack Foods
JJSF
$1.67B
| $1.24M | ﹤0.01% |
8,290
+334
| +4% | +$49.5K |
|
1839
CAE Inc. Common Shares
CAE
$8.66B
| $1.24M | ﹤0.01% |
64,119
+4,114
| +7% | +$79K |
|
|
FINS
1840
Angel Oak Financial Strategies Income Term Trust
FINS
$419M
| $1.24M | ﹤0.01% |
96,780
+17,879
| +23% | +$231K |
|
1841
Invesco Biotechnology & Genome ETF
PBE
$287M
| $1.24M | ﹤0.01% |
19,519
-495
| -2% | -$31.4K |
|
1842
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.72B
| $1.24M | ﹤0.01% |
51,227
+1,225
| +2% | +$29.4K |
|
1843
Nuveen Variable Rate Preferred & Income Fund
NPFD
$444M
| $1.24M | ﹤0.01% |
70,533
+16,590
| +31% | +$289K |
|
1844
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.28B
| $1.24M | ﹤0.01% |
59,510
-46,025
| -44% | -$949K |
|
1845
VanEck Pharmaceutical ETF
PPH
$926M
| $1.23M | ﹤0.01% |
15,866
-15,488
| -49% | -$1.14M |
|
1846
Cabot Corp
CBT
$4.48B
| $1.23M | ﹤0.01% |
18,443
+313
| +2% | +$21.9K |
|
1847
Inspire Medical Systems
INSP
$1.72B
| $1.23M | ﹤0.01% |
4,885
-251
| -5% | -$53.5K |
|
1848
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.6B
| $1.23M | ﹤0.01% |
35,592
-23,959
| -40% | -$828K |
|
|
ARCH
1849
DELISTED
Arch Resources, Inc.
ARCH
| $1.23M | ﹤0.01% |
8,586
+723
| +9% | +$106K |
|
1850
Chemours
CC
$2.26B
| $1.22M | ﹤0.01% |
39,958
-13,223
| -25% | -$397K |
|
Similar funds
VAM
Stifel Financial's Q4 2022 Portfolio in Review
As of Q4 2022, Stifel Financial held 3,449 positions worth $66.6B, up 9.1% from $61.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Stifel Financial's Q4 2022 filing shows 177 new, 1,464 increased, 1,530 reduced and 165 closed positions. Its largest new stake was Biohaven: 5,619,760 shares worth $78M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $464M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
- Stifel Financial's largest Q4 2022 buy was Biohaven: 5,619,760 shares worth $78M.
- Stifel Financial added most to iShares US Treasury Bond ETF in Q4 2022, an estimated $362M increase.
- Stifel Financial's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $363M.
- Stifel Financial fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $464M.
- Stifel Financial's ten largest holdings make up 15% of its $66.6B portfolio in Q4 2022.
- Stifel Financial opened 177 new positions and closed 165 in Q4 2022.
- Stifel Financial's portfolio value rose 9.1% quarter-over-quarter to $66.6B.
Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.